Idorsia has become the first drugmaker in the EU to claim approval for a drug for chronic insomnia in the dual orexin receptor antagonist class, ahead of rival drugs from Merck & Co and Eisai.
In an era where health care often feels impersonal and rushed, Optimum Wellbeing is changing the narrative. Founded by Drs. Paul and Kristina Jones in Westlake, the practice bridges the gap between ...